MD Logic Health x Blu Vitals Launch First Collaboration Product, Mag 9+, a Breakthrough Nine-Form Magnesium Complex
Miami, FLORIDA, Nov. 11, 2026 (GLOBE NEWSWIRE) — MD Logic Health® is collaborating with Blu Vitals, its newest cobrand, to…
Category: Globenewswire
Join Luma Named Cheapest Place to Buy Compounded Tirzepatide Online Among Seven Providers Compared for 2026
Join Luma ranks most affordable in a seven-provider comparison, with compounded tirzepatide injections from $149 per month on qualifying prepaid…
Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
– All three afimetoran doses met the primary endpoint with a placebo-adjusted difference in SRI-4 response of more than 30…
23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer’s Prevention Research
Partnership pairs 23andMe Research Institute’s consented research community with novel Scripps Research-led Alzheimer’s prevention study PALO ALTO, Calif., Nov. 11,…
Akari Therapeutics Participates in Virtual Investor “What This Means” Segment Featuring Newly Appointed Chief Business Officer Vatnak Vat-Ho
Discussion highlights Vat-Ho’s oncology business development experience, his decision to join Akari and the potential of the Company’s novel PH1…
Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London
CAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) — Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on…
Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London
THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today…
Five Presentations, One Leading Innovation: Humacyte’s Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026
– Presentations include interim Phase 3 results in women, integrated outcomes from three Phase 3 dialysis access trials and long-term…
aTyr Pharma to Participate in Upcoming Investor Conferences
SAN DIEGO, Nov. 11, 2026 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in…
ImvivaBio Presents Longer-Term Data from Clinical Studies of CTA313 Allogeneic CAR-T Therapy in Lupus at the American College of Rheumatology Convergence 2026
BOSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) — ImvivaBio, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced…